Hormone therapy is commonly combined with radiation therapy for prostate cancer, but patients are often unsure how long it should be continued and why. A new study published in JAMA Oncology from ...

Vyvanse has overtaken Ozempic as Australia's fastest‑growing prescription medication, with almost 2.2million subsidised ...

First Alert, USAA, and ADT Lead 2026 America’s Most Trusted® Safety Studies NEWPORT BEACH, CA, UNITED STATES, January ...

PSMAddition is an international, open-label, prospective, phase 3 randomized controlled trial of 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC.

In men with hormone-sensitive metachronous oligometastatic prostate cancer, the use of stereotactic body radiotherapy (SBRT) commonly delayed the need for long-term ADT and provided durable disease ...

Paid home care is buckling under the surging demands of an aging population. But there are alternatives that could upgrade jobs and improve patient care. By Paula Span You’re ready to leave the ...

Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as demonstrated by the PRESTO, EMBARK, and ENZARAD trials. The PRESTO trial ...

Combination therapy with ADT and ARPIs is now the standard for mCSPC, replacing ADT monotherapy. PSMA-PET scanning has become the standard for staging and monitoring, surpassing traditional imaging ...

ADT has confirmed that its subscribers will have to wait a bit longer to access Google Home’s new Gemini features, but nothing is breaking for the time being. Through Google’s partnership with ADT, ...

I’ve been working with computers for ages, starting with a multi-year stint in purchasing for a major IBM reseller in New York City before eventually landing at PCMag (back when it was still in print ...